C4 Therapeutics shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of C4 Therapeutics (CCCC) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in C4 Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including C4 Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in C4 Therapeutics by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $462k | 99k | 4.67 |
| 2025-03-31 | $74k | 46k | 1.60 |
| 2024-09-30 | $223k | 39k | 5.70 |
| 2024-06-30 | $138k | 30k | 4.62 |
| 2023-03-31 | $81k | 26k | 3.14 |
| 2022-12-31 | $105k | 18k | 5.90 |
| 2022-09-30 | $153k | 18k | 8.75 |
| 2022-06-30 | $139k | 18k | 7.54 |
| 2022-03-31 | $649k | 27k | 24.05 |
| 2021-12-31 | $1.8M | 56k | 32.53 |
| 2021-09-30 | $1.1M | 24k | 44.55 |
| 2021-06-30 | $835k | 22k | 38.19 |
| 2021-03-31 | $269k | 7.2k | 37.33 |
| 2020-12-31 | $252k | 7.9k | 32.00 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft